Skip to content

A study to see the efficacy of Low dose Radiation Therapy for control of symptoms in elderly patients suffering from Osteoartharitis.

A Prospective Single arm Study to assess the Efficay of Low Dose Radiation Therapy for Control of symptoms in Elderly patients suffering from Osteoartharitis. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076610
Enrollment
96
Registered
2024-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M15-M19- Osteoarthritis

Interventions

Intervention1: RADIOTHERAPY: 3 Gy in 6 fractions , one fraction per day, 2 days a week Control Intervention1: Not applicable: Not applicable

Sponsors

AMIYA GOPAL RANJA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 50 years or more 2. OA of any joint with pain, disability or deterioration of Quality of life not adequately controlled with exercise, tropical analgesics and single NSAIDS. 3. Kellgren â?? Lawrence grade 3 patients and grade 4 patients if they are not candidate for joint replacement due to concurrent morbidity making them unfit for surgery or has refused surgery due to any reason. 4. Patients who has inadequate pain control on analgesics currently on. 5. A person who understands the eligibility requirements for the study and has signed the consent form.

Exclusion criteria

Exclusion criteria: 1.History of affected joints irradiation in the past. 2.Patient participating in other degenerative arthritis clinical trials 3.Kellgren- Lawrence grade 4 except for those included due to non- feasibility of surgery. 4. History of malignancy within the last 5 years. 5. Uncontrolled comorbid conditions. 6. History of collagen vascular diseases. 7. Patients who are scheduled for surgical treatment of that joint during the clinical trial. 8. BMI more than 39Kg/m2. 9. Known history of analgesic or substance abuse within 2 years of screening. 10. Patient having any psychiatric disease. Fibromyalgia history or diagnosis.

Design outcomes

Primary

MeasureTime frame
pain Relief by VASTimepoint: 4weeks,4 months,8 months and 12 months

Secondary

MeasureTime frame
change in radiological status of OATimepoint: 4 months, and 12 months

Countries

India

Contacts

Public ContactDr Suparna Kanti Pal

IPGMER AND SSKM HOSPITAL

alokeghoshdastidar@yahoo.com9831118494

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026